CIK 0000842023 · Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411427402
- Phone
- 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-15 | Bohnen Shane SVP - General Counsel | Option exercise · Restricted Stock Units | −2,332 | 4,664 | ||
| 2026-08-15 | Kelderman Kim Chief Executive Officer | Option exercise | +21,470 | 93,583 | ||
| 2026-08-15 | Kelderman Kim Chief Executive Officer | Shares withheld for taxes | −10,821 | $72.40 | $783K | 82,762 |
| 2026-08-15 | Kelderman Kim Chief Executive Officer | Option exercise · Performance Restricted Stock Units | −554 | 8,319 | ||
| 2026-08-15 | Kelderman Kim Chief Executive Officer | Returned to the company · Performance Restricted Stock Units | −8,319 | 0 | ||
| 2026-08-15 | Kelderman Kim Chief Executive Officer | Returned to the company · Performance Stock Options (Right to Buy) | −22,389 | 1,492 | ||
| 2026-08-15 | Kelderman Kim Chief Executive Officer | Option exercise · Performance Restricted Stock Units | −588 | 8,835 | ||
| 2026-08-15 | Kelderman Kim Chief Executive Officer | Returned to the company · Performance Restricted Stock Units | −8,835 | 0 | ||
| 2026-08-15 | Kelderman Kim Chief Executive Officer | Returned to the company · Performance Stock Options (Right to Buy) | −24,324 | 1,621 | ||
| 2026-08-15 | Kelderman Kim Chief Executive Officer | Option exercise · Restricted Stock Units | −8,543 | 8,544 | ||
| 2026-08-15 | Kelderman Kim Chief Executive Officer | Option exercise · Restricted Stock Units | −11,785 | 23,569 | ||
| 2026-08-15 | Hippel James CFO | Option exercise | +9,779 | 174,493 | ||
| 2026-08-15 | Hippel James CFO | Shares withheld for taxes | −4,310 | $72.40 | $312K | 170,183 |
| 2026-08-15 | Hippel James CFO | Option exercise · Performance Restricted Stock Units | −866 | 12,999 | ||
| 2026-08-15 | Hippel James CFO | Returned to the company · Performance Restricted Stock Units | −12,999 | 0 | ||
| 2026-08-15 | Hippel James CFO | Returned to the company · Performance Stock Options (Right to Buy) | −34,982 | 2,332 | ||
| 2026-08-15 | Hippel James CFO | Option exercise · Restricted Stock Units | −4,010 | 4,011 | ||
| 2026-08-15 | Hippel James CFO | Option exercise · Restricted Stock Units | −4,903 | 9,807 | ||
| 2026-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Option exercise | +6,416 | 26,919 | ||
| 2026-08-15 | Geist William PRESIDENT, PROTEIN SCIENCES | Shares withheld for taxes | −1,976 | $72.40 | $143K | 24,943 |
Page 4 of 32 · 626 trades